Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1361, 2002-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab therapy is effective in reducing clinical symptoms of severe atopic dermatitis in adults
Inpharma, Vol. 1, Iss. 1580, 2007-01 ,pp. :
Pimecrolimus cost effective in mild to moderate atopic dermatitis
Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. :
Pimecrolimus: an effective long-term therapy for atopic dermatitis
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :